Shots:
- India has granted the emergency use approval for AstraZeneca and the Oxford University’s COVID-19 vaccine developed by a day after an advisory panel of CDSCO issued its recommendation
- Covishield would be the first vaccine to be given the go-ahead by drug regulators in India. SII and AstraZeneca have partnered up to manufacture and distribute the vaccine in India and several other countries
- Discussion for the EUAs are underway for Bharat Biotech’s COVAXIN, Zydus Cadila’s ZyCoV-D, and Russia’s Sputnik-V. India plans to inoculate 300M of its 1.35B people in the first six to eight months of 2021
Click here to read full press release/ article | Ref: Hindustan Times | Image: The Economic Times
The post AstraZeneca’s COVISHIELD Receives EUA in India for COVID-19 first appeared on PharmaShots.
